Analytical characterization of the APTIMA® HPV Assay
- 31 July 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 45, S39-S47
- https://doi.org/10.1016/s1386-6532(09)70007-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical CancerThe New England Journal of Medicine, 2007
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Epidemiologic Profile of Type‐Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa RicaThe Journal of Infectious Diseases, 2005
- Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening ProcessJNCI Journal of the National Cancer Institute, 2005
- Classification of papillomavirusesVirology, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerThe New England Journal of Medicine, 2003
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003
- Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up studyBMJ, 2002
- Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical CancerThe New England Journal of Medicine, 1999
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999